Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Ketotifenum

    • Product Name Ketotifenum
    • Alias Ketotifen
    • Einecs 263-964-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    484467

    generic_name Ketotifen
    brand_name Ketotifenum
    drug_class Antihistamine
    formulation Tablet
    strength 1 mg
    route_of_administration Oral
    indication Allergic conditions (such as asthma, allergic rhinitis)
    mechanism_of_action Mast cell stabilizer and histamine H1 receptor antagonist
    contraindications Hypersensitivity to ketotifen or excipients
    common_side_effects Drowsiness, dry mouth, weight gain
    pregnancy_category C
    storage_conditions Store below 25°C, protect from light and moisture
    prescription_status Prescription only
    manufacturer Varies by region
    ATC_code R06AX17

    As an accredited Ketotifenum factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Ketotifenum features a white box, blue accents, and contains 30 tablets, each with 1 mg of active ingredient.
    Shipping **Ketotifenum** should be shipped in tightly sealed, chemical-resistant containers, compliant with local and international regulations. During transportation, protect from light, moisture, and extreme temperatures. Label packages with appropriate hazard warnings. Handle carefully to prevent breakage and spills. Ensure shipping documentation includes safety data sheets and emergency procedures.
    Storage **Ketotifenum** should be stored in a tightly closed container, protected from light and moisture. Keep it at room temperature, ideally between 15°C and 30°C (59°F–86°F), in a well-ventilated, dry area away from incompatible substances. Ensure storage in a designated chemical storage area, clearly labeled, and out of reach of unauthorized personnel, children, and pets.
    Application of Ketotifenum

    Applications of Ketotifenum in Industrial Manufacturing

    As a dedicated manufacturer of Ketotifenum, we supply this raw material to a variety of industries where strict regulation, precise formulation, and specialized processing define downstream integration. Below, we outline the primary industrial applications, compliance requirements, technical usage parameters, and key processed end products for Ketotifenum.

    1. Pharmaceutical Antiallergic Formulations

    Pharmaceutical companies utilize Ketotifenum as an active pharmaceutical ingredient in the development of oral and topical anti-allergic medications. Manufacturers conduct phase-specific formulation under controlled environments, incorporating Ketotifenum for its non-sedating antihistaminic properties. Each batch undergoes validation according to pharmacopeial standards, with attention to residual solvents, assay, and trace impurity profiles. Preparation involves precise granulation or suspension methods, followed by tablet compression, ointment mixing, or syrup blending for chronic allergy management products.

    Industry compliance standards

    • United States Pharmacopeia (USP 43–NF38)
    • European Pharmacopoeia (Ph. Eur. 10.0)
    • Good Manufacturing Practice (GMP) as per 21 CFR 210/211
    • China National Medical Products Administration (NMPA) Drug Master File

    Typical usage ratio

    • Tablets: 0.5–2 mg per unit, depending on therapeutic target and regulatory dossier
    • Syrups: 1–2 mg/5 mL, adjusted for patient age group and dosage form stability
    • Topical formulations: 0.05–0.2% (w/w), customized based on skin penetration studies

    Downstream process integration

    • Solution phase blending for syrups prior to filling
    • Direct compression with excipients in tablet manufacturing
    • Incorporation at controlled temperatures into ointment bases

    Final product types

    • Prescription allergy tablets (monotherapy and combination)
    • Paediatric and adult allergy syrups
    • Dermatological ointments and creams for allergic dermatitis

    2. Ophthalmic Drug Manufacturing

    Ophthalmic manufacturers implement Ketotifenum for sterile eye drop production targeted at acute and chronic allergic conjunctivitis treatment. Operators dissolve and filter the raw material in aqueous, buffered vehicles under aseptic conditions, applying advanced sterilization protocols to meet stringent regulatory benchmarks. Formulation engineering focuses on isotonicity, pH adjustment, and preservation during scale-up to ensure product safety and comfort at the ocular surface. Final vials undergo batch-by-batch microbiological and particle testing before market release.

    Industry compliance standards

    • European Pharmacopoeia monographs on ophthalmic preparations
    • FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing
    • Japanese Pharmacopoeia (JP XVIII) standards
    • ISO 14644 Cleanroom standards for sterile areas

    Typical usage ratio

    • Ophthalmic solutions: 0.025% (w/v), the industry-standard concentration for antiallergic therapy

    Downstream process integration

    • Dilution and dissolution in sterile, pyrogen-free water
    • Filtration into pre-sterilized filling lines
    • Precision metering into single-dose or multi-dose dropper bottles

    Final product types

    • Allergic conjunctivitis eye drops for retail pharmacy and clinical use

    3. Active Ingredient for Veterinary Pharmaceuticals

    Veterinary drug manufacturers formulate Ketotifenum into oral and injectable products for companion animal use, particularly for managing allergic bronchitis and atopic conditions in dogs, cats, and horses. Manufacturing lines blend the ingredient into palatable suspensions or sterile injectable solutions, following animal health regulatory frameworks. Quality teams verify identity, potency, and residue limits through HPLC and validated bioassays. Manufacturers scale formulations in accordance with species weight, anticipated metabolism, and target dosing compliance.

    Industry compliance standards

    • VICH GL1-GL55 (Veterinary International Cooperation on Harmonisation)
    • European Medicines Agency (EMA) veterinary medicinal product guidelines
    • US FDA Center for Veterinary Medicine (CVM) standards
    • Good Laboratory Practice (GLP) for veterinary APIs

    Typical usage ratio

    • Oral solutions: 0.5–1 mg/kg body weight, titrated per animal species
    • Injectable formulations: 1 mg/mL, adjusted for dosage volume and frequency

    Downstream process integration

    • Pre-mixing with flavoring agents for oral suspensions
    • Sterile solution preparation and aseptic filling for injectables
    • Packaging in veterinary-grade bottles or syringes

    Final product types

    • Veterinary oral suspensions for allergic bronchitis in horses
    • Injectables for companion animal atopy

    4. Research Chemical Supply for Drug Discovery and Preclinical Studies

    Contract research organizations and pharmaceutical R&D laboratories use precise grades of Ketotifenum in preclinical screening, in vitro pharmacology, and pharmacokinetic studies. The compound serves as a reference standard in cell culture assays and animal models for mechanistic research into mast cell stabilization and antihistaminic pathways. Supplied materials meet analytical reference standards with traceable certificates of analysis, purity profiling, and residual solvent validation to ensure study reproducibility and data integrity.

    Industry compliance standards

    • ICH Q7A Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • OECD Principles of Good Laboratory Practice (GLP)
    • ISO/IEC 17025 laboratory accreditation

    Typical usage ratio

    • Assay concentrations: 0.01–10 μM, determined by target cell line or animal species
    • Formulation for in vivo: 0.5–2 mg/kg dosage range, based on research protocol design

    Downstream process integration

    • Dissolution in appropriate solvents for in vitro screening
    • Micronization for uniform distribution in preclinical formulations
    • Direct addition to test system or animal feed in controlled dosing studies

    Final product types

    • Reference standards for pharmacological assays
    • Preclinical batch supplies for animal toxicology and absorption studies

    5. Contract Manufacturing for Generic Finished Dosage Forms

    Generic pharmaceutical CDMOs use Ketotifenum during the large-scale manufacturing of authorized generic anti-allergy therapies, including replicating branded reference formulations for global export. Facilities employ controlled granulation, tablet press calibration, and validated coating machines to produce uniform and bioequivalent final products. Documentation for every lot aligns with ANDA submission dossiers and respective country-specific monograph standards, ensuring all in-process and finished batch specifications are met and fully traceable.

    Industry compliance standards

    • FDA Abbreviated New Drug Application (ANDA) requirements
    • WHO Prequalification Programme guidelines
    • EU EudraLex, Volume 4: GMP for Medicinal Products for Human and Veterinary Use
    • Indian Schedule M (Drugs and Cosmetics Rules)

    Typical usage ratio

    • Single-ingredient tablets: 1 mg per tablet, following established generic composition
    • Combination products: 0.5–1 mg per tablet, adjusted per therapeutic indication and reference product profile

    Downstream process integration

    • High-shear mixer and fluid bed dryer integration for uniform API distribution
    • Tableting line entry following validated blending
    • Pilot and commercial scale film-coating with quality sampling

    Final product types

    • Generic anti-allergy oral solid dosage forms
    • Export-labelled bulk tablets for pharmaceutical repackagers
    Free Quote

    Competitive Ketotifenum prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Ketotifenum: Practical Insights From The Manufacturer

    Bringing Ketotifenum To The Forefront Of Pharmaceutical Applications

    Manufacturing Ketotifenum takes a focused approach, and our facility has spent years refining the process that brings this crucial active ingredient to the global market. As the team handling each stage — from synthesis to packaging — we've learned a lot about the science behind this compound and the practical expectations of formulators and downstream users. For anyone formulating allergy relief medicines, topical anti-itch preparations, or working to meet strict pharmacopoeia requirements, understanding a molecule’s origins and unique properties lays the groundwork for consistent quality in the finished dose.

    Ketotifenum: Model, Grades, and The Difference Our Process Makes

    We produce Ketotifenum as a pure, crystalline substance intended primarily for pharmaceutical use, with a model that aligns with the molecular structure C19H19NO3S. Quality goes beyond purity on paper. Our most recent production runs consistently achieve an assay of over 99.5% (on dried basis). For several years, the fight has been to not just hit the minimum standard but to make the product easier for downstream tablet manufacturers and compounding pharmacists. One real-world challenge is how trace residual solvents or color impurities can cause headaches later in the pipeline. Meeting — and often exceeding — the specifications listed in the European Pharmacopeia and United States Pharmacopeia has come from fine-tuning solvent control and recrystallization protocols.

    By steering away from unnecessarily complex additive systems, we’ve created a product that dissolves quickly in the manufacturing medium, yielding clear and stable solutions for further processing. This attribute comes directly from in-house optimization. Unlike many generic options that rely on less stringent purification steps, our material stands up to scrutiny during both small-scale laboratory analysis and full-scale production validation, leading to ease during blending and tableting.

    Applications: Using Ketotifenum In Real-World Formulations

    Formulators rely on Ketotifenum as a non-corticosteroid solution to address allergic conjunctivitis and certain types of rhinitis. Our customers — including mid-size generic drug producers, hospital compounding centers, and research institutions — consistently express the need for predictable reaction profiles and stability. They work across oral, topical, and ophthalmic preparations. From our vantage point, reproducibility is not just a buzzword. Each batch is torqued toward meeting rigid photostability standards, ensuring that drops or tablets hold up during shipping, at point-of-care dispensing, or even in regions where ambient temperatures fluctuate.

    A large share of requests we fill are for fine, needle-shaped crystals with consistent bulk density, as this makes blending into oral tablets more efficient and cuts down on loss during handling. The same goes for powders milled to pass through a 60-mesh sieve for solution preparations. Many partners have shared their challenges with lump formation when working with off-brand material from traders or secondary processors. Fine-tuning particle morphology has been a multi-year initiative for our process engineers, who spend years mastering equipment parameters and process flow.

    Manufacturing Controls: Learning In The Trenches

    Manufacturing Ketotifenum brings unique challenges. Take water control for example: during certain reaction steps, even a trace of moisture can cause unwanted byproducts or color formation. Controlling this comes down to real-world details, like maintaining overpressure with dry nitrogen and revalidating drier integrity after each maintenance cycle. Equipment cleaning, especially for glass-lined reactors, matters more than just ticking a box on a checklist; old residues from previous runs can catalyze unexpected reactions, especially when dealing with sensitive aromatic substitution steps. Investing in stainless steel upgrades and single-use transfer lines solved cross-batch contamination issues after several years of battling these in our own suites.

    For a long time, industry guidelines set by pharmacopeias gave little practical guidance about actual manufacturing variability from one site to another. Collaborating with formulation partners led to process bulletins and detailed reviews with their QA teams, which in turn led us to adjust everything from cGMP documentation practices to storage stability protocols. Each small improvement compounds into more reliable release profiles in end-user laboratories — which we've seen ourselves when testing retained samples against newer lots.

    How Our Ketotifenum Stands Apart From Other Products

    Over the years, we've heard firsthand about the pitfalls users face when sourcing from resellers or brokers who offer inconsistent lots. One year, we analyzed several competitor samples and found unexplained color tints and high peroxide values — both signal stability issues down the line. This is a direct consequence of aging stocks and improper storage. For our product, we run ongoing trend analysis of impurity profiles. Any deviation, even if within regulatory limits, prompts a root-cause review by our QA team. As a result, our partners report fewer instances of failed dissolution tests and avoided loss of finished goods, which saves time and money at multiple stages.

    From a practical standpoint, many alternative sources cut corners on particle size control, leading to problems during blending or inhomogeneous mixing. Several customers have replaced less reliable sources with our Ketotifenum following field complaints about gritty suspensions in eye drops or tablets that failed content uniformity. While some labs attempt to reprocess and re-mill off-grade material, our experience shows that consistent morphology from the outset drives manufacturing efficiency and reduces waste.

    Sourcing directly from our facility provides another advantage — block chain of custody and traceable batch records. Intermediary suppliers sometimes lose sight of full documentation, while our partners have access to detailed certificates, validated transportation protocols, and unique batch-level analytics that have stood the test under international regulatory inspection.

    Consistency Drives Trust

    Longer term customers stay with us because of the reliability we bring — not simply because of a price point, but because it makes their own manufacturing or compounding predictable. During a decade working in this industry, feedback loops with downstream product developers and healthcare professionals have shaped the details of our QC methodology. It’s not about generic checklists. Each product release ties back to deeper hands-on involvement, whether that means carrying out additional photostability testing in the midsummer months or adjusting packaging to minimize the ingress of atmospheric moisture on intercontinental shipments.

    Every few months, we evaluate shipment temperature logs, reviewing data collected from shipments that crossed hot climates, and discuss real-world degradation scenarios, not just theoretical ones. By updating packaging and storage recommendations, we've prevented issues like aggregation which often show up in material that sits too long at a port or customs warehouse. These precautions help our customers avoid last-minute headaches during incoming inspection or at batch record review.

    Partnerships Matter: Collaboration Beyond The Sale

    Years of partnering with pharmaceutical developers and R&D scientists have shown that a dialogue between the manufacturing floor and the formulation lab creates stronger products. Our plant hosts annual reviews with key buyers to discuss sample performance, complaints, and new regulatory needs. One such meeting led to a reformulation of a packaging insert after clients in tropical regions asked for more humidity protection. It’s easy to treat each order as a transaction, but our history tells us that walking production lines with our partners, reviewing process parameters, and sitting in during their validation runs have led to fewer surprises and better-performing products.

    Several collaborations began with requests for micro-lot samples to trial new eyedrop formulations. Later, these partners came back for process-scale quantities, requesting minor adjustments in crystal habit or packaging size. Our job, as we see it, is to serve as both manufacturer and technical ally, troubleshooting during pilot scale-up, reviewing impurity retention times, and offering insight based on the cumulative experience from hundreds of commercial scale batches.

    Regulatory Realities

    Each year brings new scrutiny and shifting requirements in regulated markets like the US, EU, and certain Asian jurisdictions. Our regulatory team receives regular audits not only on documentation but also on minute details of process validation and cleaning procedure qualifications. This attention to compliance provides buyers confidence that each delivery matches stated specifications, but it also challenges us to innovate beyond basic requirements. By investing in additional stability studies, not just during launch but for ongoing commercial production, our Ketotifenum remains a reliable ingredient for customers submitting dossiers in strict approval environments. We've seen that proactive compliance, by investing in human oversight and documentation, avoids delays and supports global supply continuity even in years when shipping or trade regulations change.

    Addressing Current And Future Challenges

    As manufacturing partners, we regularly field questions from formulation chemists about residual solvents, impurity spikes, and optimal handling for increasingly complex dosage forms. Sometimes, it means working alongside teams developing slow-release systems. Other times, the focus lies with stability in multi-dose dropper vials. These daily questions shape our technical support. Recently, a client encountered a filtration problem due to an unexpected shift in their process water chemistry. After analyzing retained samples and comparing impurity traces, we identified microcontaminants not present in source Ketotifenum, traced instead to their local water source. Such partnerships turn what might begin as a simple supplier relationship into a longer-term technical support channel.

    Continuous process improvement also plays a role as technology evolves. In the past, particle size reduction relied largely on jet milling, but our team has developed methods using controlled crystallization. This approach has shaved several percentage points off of lot-to-lot variability and sparked innovation in filterability and suspensibility for finished products. Bringing in automation on our packaging lines, tied with enhanced environmental monitoring, prevents quality lapses from simple human error or unnoticed environmental drift.

    Commitment: Quality From Start To Finish

    Placing value on long-term relationships over short-term selling cycles has created a customer base that pushes us forward. Whether responding to a regulator's question, assisting with field complaint investigations, or sharing unpublished data from our internal quality programs, the focus stays on transparency and responsiveness. Years of audit experience have shown that no shortcut replaces hands-on oversight or a willingness to adapt process parameters for specific customer use cases. Feedback from our oldest customers points to three themes: consistency, adaptability, and real communication.

    We took each lesson learned from past production issues — whether they came from equipment malfunctions, weather-driven shipping delays, or even mid-season impurity profile drift — and invested back into facilities, staff training, and client-facing technical documentation. Today, we share these insights as a practical guide to manufacturers and research chemists who depend on our Ketotifenum for their formulations.

    Final Thoughts: Delivering Reliable Ketotifenum Is A Team Effort

    Producing Ketotifenum goes deeper than simple batch output and shipping documentation. Walking the production floor, troubleshooting crystallization challenges, fielding late-night calls about shipment delays, and opening up QC logs to clients facing audit questions — these activities create a team that stands behind every package. The credibility that comes from years of meeting tough customer standards keeps our process dynamic. Feedback — good and bad — finds its way into continuous improvement cycles. Our approach means that formulators, QC managers, and even regulatory reviewers encounter a production partner who listens, adapts, and commits resources where needed.

    We know every lot of Ketotifenum carries the reputation of both our company and our partners. The technical stories passed along by client teams, the troubleshooting that happens during scale-up failure, and the incremental process improvements made in response to each round of external audit — all of these shape the final product. In sharing these experiences, we hope to help both new and longstanding partners achieve their quality goals and build resilient supply chains for years to come.